JRUD:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - USD (inc) (USD)

ETF | Others |

Last Closing

USD 47.9325

Change

+0.72 (+1.51)%

Market Cap

USD 0.43B

Volume

20.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

-0.43 (0.00%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

-1.75 (-0.94%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.17%)

USD 642.91B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.10%)

USD 636.40B
0R1I:LSE NVIDIA Corp.

-3.70 (-0.39%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-13.50 (-0.66%)

USD 320.04B
0QZK:LSE Coca-Cola Co.

-0.40 (-0.63%)

USD 266.08B
0QZO:LSE 0QZO

-0.40 (-0.39%)

USD 258.54B

ETFs Containing JRUD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.35% 75% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.35% 75% C 70% C-
Trailing 12 Months  
Capital Gain 26.55% 87% B+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.55% 86% B+ 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.58% 71% C- 72% C
Dividend Return 9.58% 70% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.30% 62% D 76% C+
Risk Adjusted Return 84.75% 93% A 95% A
Market Capitalization 0.43B 67% D+ 58% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike